Bilcare Ltd BSE receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Metrics to compare | BIL | Sector Sector - Average of metrics from a broad group of related Basic Materials sector companies | Relationship RelationshipBILPeersSector | |
|---|---|---|---|---|
P/E Ratio | 20.1x | 12.1x | −0.4x | |
PEG Ratio | 0.14 | 0.08 | 0.00 | |
Price/Book | 1.1x | 1.1x | 2.6x | |
Price / LTM Sales | 0.3x | 2.1x | 3.1x | |
Upside (Analyst Target) | - | 13.9% | 49.4% | |
Fair Value Upside | Unlock | 14.5% | 6.8% | Unlock |
Bilcare Limited provides pharmaceutical packaging research solutions in India and internationally. The company offers aluminum foils, polymer films, and anti-counterfeiting packaging solutions for solid dosage pharmaceutical products and other applications; and blister films and foils, lidding foils, cr foils, and laminates. It also engages in the provision of clinical trial supplies, clinical trial management, and brand protection technologies services; and research and development services comprising formulation stability studies, blister/foil design and development, pharma brand innovation, analytical research and market study, and packaging trials and audit. Bilcare Limited was incorporated in 1987 and is headquartered in Pune, India.